Person: John Chen

Dr Michael Berendt

Dr Michael Berendt has been appointed CEO of Bioniche Life Sciences Inc, effective immediately, replacing company founder and CEO Graeme McRae, who is retiring but retains the title of chairman emeritus of the board of directors (R$, September 26/13). Berendt was recently president and CEO of Montreal-based Aegera Therapeutics Inc. until it was sold to…

John Chen

John Chen will become interim CEO of Blackberrry Ltd and executive chair of its board of directors upon the closing of a $1-billion private placement in the company, expected by November 18th. He replaces Thorsten Heins, who has led the Waterloo ON-based firm through two turbulent years in which it has lost market share, posted…

Jim Ghadbane

Jim Ghadbane has been appointed president and CEO of CANARIE, effective November 11, replacing Jim Roche who has held the position twice over the past four years (R$, June 21/13). Ghadbane joined CANARIE in May/10 as interim chief technology officer and was made permanent the following year. During that time he has led several strategic…